Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis
Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis have?
Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis has 1 citations in the OpenAlex counts PICO Portal stores.
When was Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis published?
Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis has 2025 year in the PICO Portal index.
What is the open-access status of Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis?
Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis has closed oa status in the PICO Portal index.
What is the DOI of Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis?
The DOI for Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis is on the source record.
What is the OpenAlex record for Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis?
The OpenAlex for Modulator Therapy: A Narrative Review of the Triple Combination of Tezacaftor, Elexacaftor, and Ivacaftor in the Management of Cystic Fibrosis is on the source record.